Table 2.
Five-year relative survival by histologic type and country/region (all ages)
| Histologic Type | Region (organization) | Years | 5 y |
|
|---|---|---|---|---|
| Rate | 95% CI | |||
| Pilocytic astrocytoma | US1 (CBTRUS) | 1995–2010 | 94.4 | 93.4–95.2 |
| ICD-O-3 morphology code 9421 | UK & Ireland18 (EUROCARE) | 1995–2002 | 80.6 | 68.4–88.6 |
| Northern Europe18 (EUROCARE) | 1995–2002 | 81.9 | 68.4–90.3 | |
| Central Europe18 (EUROCARE) | 1995–2002 | 79.7 | 62.6–89.9 | |
| Eastern Europe18 (EUROCARE) | 1995–2002 | 57.3 | 33.5–75.8 | |
| Southern Europe18 (EUROCARE) | 1995–2002 | 97.3 | 74.7–100.0 | |
| Astrocytoma, NOS | US1 | 1995–2010 | 47.3 | 45.8–48.7 |
| ICD-O-3 morphology codes 9440, 9410, 9420 | Korea20 | 1994–2004 | 51.6 | |
| UK & Ireland18 (EUROCARE) | 1995–2002 | 39.0 | 34.7–43.3 | |
| Northern Europe18 (EUROCARE) | 1995–2002 | 49.4 | 42.7–55.8 | |
| Central Europe18 (EUROCARE) | 1995–2002 | 35.4 | 29.9–40.9 | |
| Eastern Europe18 (EUROCARE) | 1995–2002 | 28.0 | 22.5–33.8 | |
| Southern Europe18 (EUROCARE) | 1995–2002 | 42.6 | 33.9–51.1 | |
| Anaplastic astrocytoma | US1 | 1995–2010 | 26.5 | 24.8–28.2 |
| ICD-O-3 morphology code 9401 | Korea20 | 1994–2004 | 25.2 | |
| UK & Ireland18 (EUROCARE) | 1995–2002 | 17.6 | 13.5–22.2 | |
| Northern Europe18 (EUROCARE) | 1995–2002 | 10.8 | 7.8–14.4 | |
| Central Europe18 (EUROCARE) | 1995–2002 | 28.8 | 19.3–39.0 | |
| Eastern Europe18 (EUROCARE) | 1995–2002 | 11.7 | 7.1–17.4 | |
| Southern Europe18 (EUROCARE) | 1995–2002 | 18.1 | 11.8–25.4 | |
| Glioblastoma | US1 | 1995–2010 | 4.7 | 4.4–5.0 |
| ICD-O-3 morphology codes 9440–9442 | Korea20 | 1994–2004 | 8.9 | |
| US154 | 1997–2000 | 0.1 | ||
| UK & Ireland18 (EUROCARE) | 1995–2002 | 2.2 | 1.6–2.9 | |
| Northern Europe18 (EUROCARE) | 1995–2002 | 1.9 | 1.2–2.9 | |
| Central Europe18 (EUROCARE) | 1995–2002 | 4.4 | 3.2–5.9 | |
| Eastern Europe18 (EUROCARE) | 1995–2002 | 2.2 | 1.0–4.4 | |
| Southern Europe18 (EUROCARE) | 1995–2002 | 2.8 | 1.8–4.3 | |
| Oligodendroglioma | US1 (CBTRUS) | 1995–2010 | 79.1 | 77.4–80.7 |
| ICD-O-3 morphology code 9450 | Korea20 | 1994–2004 | 73.5 | |
| UK & Ireland18 (EUROCARE) | 1995–2002 | 65.8 | 57.5–73.0 | |
| Northern Europe18 (EUROCARE) | 1995–2002 | 74.1 | 64.4–81.8 | |
| Central Europe18 (EUROCARE) | 1995–2002 | 75.5 | 61.8–85.2 | |
| Eastern Europe18 (EUROCARE) | 1995–2002 | 47.8 | 32.4–62.0 | |
| Southern Europe18 (EUROCARE) | 1995–2002 | 63.8 | 51.4–74.1 | |
| Anaplastic oligodendroglioma | US1 (CBTRUS) | 1995–2010 | 50.7 | 47.5–53.8 |
| ICD-O-3 morphology codes 9451, 9460 | Korea20 | 1994–2004 | 50.4 | |
| UK & Ireland18 (EUROCARE) | 1995–2002 | 35.5 | 24.4–46.9 | |
| Northern Europe18 (EUROCARE) | 1995–2002 | 35.1 | 21.2–49.5 | |
| Central Europe18 (EUROCARE) | 1995–2002 | 29.7 | 13.4–48.3 | |
| Eastern Europe18 (EUROCARE) | 1995–2002 | 6.1 | 1.3–16.6 | |
| Southern Europe18 (EUROCARE) | 1995–2002 | 33.3 | 14.7–53.6 | |
| Oligoastrocytoma | US1 (CBTRUS) | 1995–2010 | 61.0 | 58.3–63.6 |
| ICD-O-3 morphology code 9382 | England & Wales19 | 1971–1995 | 39.0 | |
| Astrocytic tumors | England & Wales19 | 1971–1995 | 10.0 | |
| ICD-O-3 morphology codes 9380–9382, 9384, 9400–9442 and site codes C71, C72.0, C72.8–C72.9 | Europe5 (RARECARE) | 1995–2002 | 15.0 | |
| Oligodendroglial tumors | England & Wales19 | 1971–1995 | 39.6 | |
| ICD-O-3 morphology codes 9450–9451, 9460 and site codes C71, C72.0, C72.8–C72.9 | Europe5 (RARECARE) | 1995–2002 | 55.0 | |
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; EUROCARE, European Cancer Registry Based Study on Survival and Care of Cancer Patients; NOS, not otherwise specified; RARECARE, Surveillance of Rare Cancer in Europe (EU).